Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

Market Cap	3.74B +22.5%
Revenue (ttm)	1.10B +11.9%
Net Income	120.51M +4.0%
EPS	1.15 +6.6%
Shares Out	105.91M
PE Ratio	30.74
Forward PE	n/a
Dividend	0.20 (0.57%)
Ex-Dividend Date	Sep 16, 2025

Volume	2,644,300
Average Volume	7,276,720
Open	34.63
Previous Close	35.35
Day's Range	34.58 - 35.38
52-Week Range	24.05 - 42.88
Beta	-0.41
RSI	52.00
Earnings Date	Apr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 933
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2024, SHE:002864's revenue was 973.86 million, a decrease of -0.71% compared to the previous year's 980.83 million. Earnings were 120.27 million, an increase of 8.91%.